Tiova Rotacap: Advanced Bronchodilation for COPD Management
| Product dosage: 18 mcg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 30 | $1.51 | $45.18 (0%) | 🛒 Add to cart |
| 60 | $1.31 | $90.37 $78.32 (13%) | 🛒 Add to cart |
| 90 | $0.96
Best per cap | $135.55 $86.35 (36%) | 🛒 Add to cart |
Synonyms | |||
Tiova Rotacap (Tiotropium Bromide) is a long-acting muscarinic antagonist (LAMA) inhalation powder indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is designed to improve lung function, reduce exacerbations, and enhance overall quality of life through sustained bronchodilation. Administered via the Rotahaler device, it ensures efficient drug delivery to the lungs with a once-daily dosing regimen for patient convenience and adherence.
Features
- Contains Tiotropium Bromide 18 mcg per capsule
- Delivered via Rotahaler dry powder inhaler
- Once-daily dosing for 24-hour bronchodilation
- Pre-measured single-dose capsules for accuracy
- Low systemic absorption due to localized action
- Compatible with standard COPD management protocols
Benefits
- Provides sustained bronchodilation, improving airflow for 24 hours after each dose
- Reduces the frequency and severity of COPD exacerbations
- Enhances exercise tolerance and daily activity performance
- Minimizes the need for rescue medications
- Supports long-term lung function preservation
- Improves overall health-related quality of life scores
Common use
Tiova Rotacap is routinely prescribed for the maintenance treatment of airflow obstruction in patients with COPD. It is not indicated for the relief of acute bronchospasm and should be used as a part of a comprehensive management plan that may include pulmonary rehabilitation, smoking cessation, and other pharmacotherapies. It is especially beneficial for patients who require consistent control of symptoms and prevention of exacerbations.
Dosage and direction
The recommended dosage is the inhalation of the contents of one Tiova Rotacap (18 mcg) once daily, at the same time each day, using the Rotahaler device. The capsule should not be swallowed. Instructions for use:
- Remove one capsule from the blister strip immediately before use.
- Open the Rotahaler by twisting the mouthpiece.
- Insert the capsule into the chamber; close the device.
- Press the button on the side of the Rotahaler to pierce the capsule.
- Breathe out fully, place the mouthpiece between lips, and inhale deeply and steadily.
- Hold breath for up to 10 seconds, then exhale slowly.
- Check the chamber to ensure the capsule is empty; discard it after use.
Do not exceed the prescribed dose. If a dose is missed, refer to the “Missed dose” section.
Precautions
- Not for use in the treatment of acute episodes of bronchospasm.
- Use with caution in patients with narrow-angle glaucoma, prostatic hyperplasia, or bladder-neck obstruction.
- Immediate hypersensitivity reactions, including angioedema, may occur.
- Patients should be instructed on proper inhaler technique to avoid inadequate dosing.
- Monitor for signs of worsening COPD or paradoxical bronchospasm.
- Avoid getting the powder in the eyes, as it may cause blurring of vision or pupil dilation.
Contraindications
Tiova Rotacap is contraindicated in patients with a history of hypersensitivity to tiotropium bromide, atropine or its derivatives, or any component of the formulation. It should not be used in patients with severe hypersensitivity to milk proteins.
Possible side effect
Common adverse reactions (≥1%) include:
- Dry mouth
- Upper respiratory tract infection
- Sinusitis
- Pharyngitis
- Constipation
- Dyspepsia
- Headache
Less common but serious side effects may include:
- Glaucoma
- Urinary retention
- Tachycardia
- Allergic reactions such as rash, itching, or swelling
Patients should seek medical attention if they experience eye pain, difficulty urinating, palpitations, or severe allergic symptoms.
Drug interaction
- Concomitant use with other anticholinergic agents may potentiate adverse effects.
- No clinically significant interactions observed with sympathomimetic bronchodilators, methylxanthines, or oral or inhaled steroids.
- Use caution with drugs that are excreted renally or affect renal function, as tiotropium is partially eliminated by the kidneys.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is nearly time for the next dose, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one.
Overdose
Overdose may lead to anticholinergic effects such as dry mouth, visual disturbances, tachycardia, and urinary retention. Treatment is supportive and symptomatic. There is no specific antidote. Dialysis is not appropriate due to high protein binding and extensive tissue distribution.
Storage
Store below 30°C in a dry place. Protect from moisture and light. Keep the capsules in the original blister packaging and remove only immediately before use. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations and to address any health concerns or before starting any new medication. Do not disregard or delay seeking professional advice based on content provided here.
Reviews
Clinical studies and patient reports consistently highlight the efficacy of Tiova Rotacap in maintaining bronchodilation, reducing dyspnea, and decreasing exacerbation rates in moderate to severe COPD. Users often note improved ability to perform daily activities and better symptom control compared to short-acting agents. Some report dry mouth as a manageable side effect. Overall, it is regarded as a cornerstone maintenance therapy in COPD management protocols.